Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 11-Mar-24 8:00 PM View:  | Boor Kathryn Jean Director | AVI Biopharma, Inc. (SRPT) | 11-Mar-24 | Private Sale | 761 | $122.93 | $93,549.70 | (9%) 8.28K to 7.52K | |
| 11-Mar-24 8:02 PM View: | Wigzell Hans Lennart Rudolf Director | AVI Biopharma, Inc. (SRPT) | 08-Mar-24 | Option Sale | 15,000 | $123.25 | $1,848,800.00 | (40%) 37.84K to 22.84K | |
| 11-Mar-24 8:00 PM View: | Arif Bilal Chief Tech Ops Officer | AVI Biopharma, Inc. (SRPT) | 08-Mar-24 | Payment of Exercise | 472 | $123.14 | $58,122.10 | (2%) 25.69K to 25.22K | |
| 11-Mar-24 8:00 PM View: | Rodino-Klapac Louise Head of R&D, CSO | AVI Biopharma, Inc. (SRPT) | 08-Mar-24 | Payment of Exercise | 909 | $123.14 | $111,934.00 | (1%) 68.98K to 68.07K | |
| 11-Mar-24 8:00 PM View: | Estepan Ian Michael Chief Financial Officer | AVI Biopharma, Inc. (SRPT) | 08-Mar-24 | Payment of Exercise | 1,035 | $123.14 | $127,450.00 | (3%) 37.2K to 36.16K | |
| 11-Mar-24 8:00 PM View: | Brown Ryan Edward EVP, General Counsel | AVI Biopharma, Inc. (SRPT) | 08-Mar-24 | Payment of Exercise | 899 | $123.14 | $110,703.00 | (3%) 29.59K to 28.69K | |
| 11-Mar-24 8:02 PM View: | Wigzell Hans Lennart Rudolf Director | AVI Biopharma, Inc. (SRPT) | 08-Mar-24 | Option Exercise | 15,000 | $13.90 | $208,500.00 | 66% 22.84K to 37.84K | |
| 11-Mar-24 8:00 PM View: | Estepan Ian Michael Chief Financial Officer | AVI Biopharma, Inc. (SRPT) | 07-Mar-24 | Payment of Exercise | 526 | $120.49 | $63,377.70 | (1%) 37.73K to 37.2K | |
| 11-Mar-24 8:00 PM View: | Brown Ryan Edward EVP, General Counsel | AVI Biopharma, Inc. (SRPT) | 07-Mar-24 | Payment of Exercise | 506 | $120.49 | $60,967.90 | (2%) 30.09K to 29.59K | |
| 11-Mar-24 8:00 PM View: | Arif Bilal Chief Tech Ops Officer | AVI Biopharma, Inc. (SRPT) | 07-Mar-24 | Payment of Exercise | 506 | $120.49 | $60,967.90 | (2%) 26.2K to 25.69K | |
| 11-Mar-24 8:00 PM View: | Rodino-Klapac Louise Head of R&D, CSO | AVI Biopharma, Inc. (SRPT) | 07-Mar-24 | Payment of Exercise | 512 | $120.49 | $61,690.90 | (< 1%) 69.49K to 68.98K | |
| 06-Mar-24 10:00 PM View: | Arif Bilal Chief Tech Ops Officer | AVI Biopharma, Inc. (SRPT) | 04-Mar-24 | Payment of Exercise | 522 | $125.32 | $65,417.00 | (2%) 26.72K to 26.2K | |
| 06-Mar-24 10:00 PM View: | Rodino-Klapac Louise Head of R&D, CSO | AVI Biopharma, Inc. (SRPT) | 04-Mar-24 | Payment of Exercise | 1,728 | $125.32 | $216,553.00 | (2%) 71.22K to 69.49K | |
| 06-Mar-24 10:00 PM View: | Estepan Ian Michael Chief Financial Officer | AVI Biopharma, Inc. (SRPT) | 04-Mar-24 | Payment of Exercise | 1,389 | $125.32 | $174,069.00 | (4%) 39.11K to 37.73K | |
| 06-Mar-24 10:00 PM View: | Brown Ryan Edward EVP, General Counsel | AVI Biopharma, Inc. (SRPT) | 04-Mar-24 | Payment of Exercise | 1,734 | $125.32 | $217,305.00 | (5%) 31.83K to 30.09K | |
| 05-Mar-24 8:00 PM View: | Mayo Stephen Director | AVI Biopharma, Inc. (SRPT) | 01-Mar-24 | Grant | 1,846 | -- | -- | 23% 7.91K to 9.76K | |
| 05-Mar-24 8:00 PM View: | Arif Bilal Chief Tech Ops Officer | AVI Biopharma, Inc. (SRPT) | 01-Mar-24 | Payment of Exercise | 365 | $126.19 | $46,059.40 | (1%) 29.09K to 28.72K | |
| 05-Mar-24 8:00 PM View: | Estepan Ian Michael Chief Financial Officer | AVI Biopharma, Inc. (SRPT) | 01-Mar-24 | Grant | 6,000 | -- | -- | 17% 34.68K to 40.68K | |
| 05-Mar-24 8:00 PM View: | Brown Ryan Edward EVP, General Counsel | AVI Biopharma, Inc. (SRPT) | 01-Mar-24 | Grant | 6,000 | -- | -- | 21% 28.1K to 34.1K | |
| 05-Mar-24 8:00 PM View: | Rodino-Klapac Louise Head of R&D, CSO | AVI Biopharma, Inc. (SRPT) | 01-Mar-24 | Payment of Exercise | 778 | $126.19 | $98,175.80 | (1%) 72.0K to 71.22K | |
| 05-Mar-24 8:00 PM View: | Wigzell Hans Lennart Rudolf Director | AVI Biopharma, Inc. (SRPT) | 01-Mar-24 | Grant | 1,846 | -- | -- | 9% 20.99K to 22.84K | |
| 05-Mar-24 8:00 PM View: | Arif Bilal Chief Tech Ops Officer | AVI Biopharma, Inc. (SRPT) | 01-Mar-24 | Sale | 2,000 | $128.84 | $257,676.00 | (7%) 28.72K to 26.72K | |
| 05-Mar-24 8:00 PM View: | Estepan Ian Michael Chief Financial Officer | AVI Biopharma, Inc. (SRPT) | 01-Mar-24 | Payment of Exercise | 365 | $126.19 | $46,059.40 | (< 1%) 40.68K to 40.31K | |
| 05-Mar-24 8:00 PM View: | Brown Ryan Edward EVP, General Counsel | AVI Biopharma, Inc. (SRPT) | 01-Mar-24 | Payment of Exercise | 269 | $126.19 | $33,945.10 | (< 1%) 34.1K to 33.83K | |
| 05-Mar-24 8:00 PM View: | Barry Richard Director | AVI Biopharma, Inc. (SRPT) | 01-Mar-24 | Grant | 1,846 | -- | -- | < 1% 3.18M to 3.18M | |
| 05-Mar-24 8:00 PM View: | Nicaise Claude Director | AVI Biopharma, Inc. (SRPT) | 01-Mar-24 | Grant | 1,846 | -- | -- | 11% 16.33K to 18.17K | |
| 05-Mar-24 8:00 PM View: | Arif Bilal Chief Tech Ops Officer | AVI Biopharma, Inc. (SRPT) | 01-Mar-24 | Grant | 6,000 | -- | -- | 26% 23.09K to 29.09K | |
| 05-Mar-24 8:00 PM View: | Rodino-Klapac Louise Head of R&D, CSO | AVI Biopharma, Inc. (SRPT) | 01-Mar-24 | Grant | 6,000 | -- | -- | 9% 66.0K to 72.0K | |
| 05-Mar-24 8:00 PM View: | Estepan Ian Michael Chief Financial Officer | AVI Biopharma, Inc. (SRPT) | 01-Mar-24 | Sale | 1,200 | $128.30 | $153,960.00 | (3%) 40.31K to 39.11K | |
| 05-Mar-24 8:00 PM View: | Brown Ryan Edward EVP, General Counsel | AVI Biopharma, Inc. (SRPT) | 01-Mar-24 | Sale | 2,000 | $125.34 | $250,680.00 | (6%) 33.83K to 31.83K | |
| 05-Mar-24 8:00 PM View: | Behrens M Kathleen Director | AVI Biopharma, Inc. (SRPT) | 01-Mar-24 | Grant | 1,846 | -- | -- | < 1% 184.99K to 186.84K | |
| 05-Mar-24 8:00 PM View: | Chambers Michael Andrew Director | AVI Biopharma, Inc. (SRPT) | 01-Mar-24 | Grant | 1,846 | -- | -- | < 1% 253.43K to 255.27K | |
| 05-Mar-24 8:00 PM View: | Boor Kathryn Jean Director | AVI Biopharma, Inc. (SRPT) | 01-Mar-24 | Grant | 1,846 | -- | -- | 29% 6.43K to 8.28K | |
| 05-Dec-23 8:00 PM View: | Arif Bilal Chief Tech Ops Officer | AVI Biopharma, Inc. (SRPT) | 01-Dec-23 | Payment of Exercise | 3,682 | $80.34 | $295,812.00 | (14%) 26.57K to 22.89K | 5% |
| 20-Nov-23 10:00 PM View: | Rodino-Klapac Louise Head of R&D, CSO | AVI Biopharma, Inc. (SRPT) | 17-Nov-23 | Payment of Exercise | 4,508 | $82.98 | $374,074.00 | (6%) 70.26K to 65.75K | 8% |
| 06-Nov-23 8:00 AM View: | Ingram Douglas S President & CEO Director | AVI Biopharma, Inc. (SRPT) | 03-Nov-23 | Market Purchase | 25,225 | $79.36 | $2,001,800.00 | 7% 365.08K to 390.31K | (4%) |
| 06-Nov-23 8:00 AM View: | Barry Richard Director | AVI Biopharma, Inc. (SRPT) | 03-Nov-23 | Market Purchase | 50,000 | $78.81 | $3,940,500.00 | 2% 3.03M to 3.08M | (3%) |
| 06-Nov-23 8:00 AM View: | Behrens M Kathleen Director | AVI Biopharma, Inc. (SRPT) | 03-Nov-23 | Option Exercise | 15,000 | $29.03 | $435,450.00 | 9% 169.99K to 184.99K | |
| 15-Aug-23 8:00 AM View: | Chambers Michael Andrew Director | AVI Biopharma, Inc. (SRPT) | 14-Aug-23 | Purchase | 9,979 | $109.47 | $1,092,430.00 | 4% 243.45K to 253.43K | |
| 14-Aug-23 8:00 AM View: | Chambers Michael Andrew Director | AVI Biopharma, Inc. (SRPT) | 11-Aug-23 | Purchase | 23,686 | $108.05 | $2,559,270.00 | 11% 219.76K to 243.45K | |
| 11-Aug-23 7:40 AM View: | Chambers Michael Andrew Director | AVI Biopharma, Inc. (SRPT) | 10-Aug-23 | Purchase | 34,867 | $106.15 | $3,701,070.00 | 19% 184.9K to 219.76K | |
| 08-Aug-23 8:00 PM View: | Wigzell Hans Lennart Rudolf Director | AVI Biopharma, Inc. (SRPT) | 04-Aug-23 | Option Sale | 15,000 | $106.72 | $1,600,800.00 | (42%) 35.99K to 20.99K | |
| 08-Aug-23 8:00 PM View: | Wigzell Hans Lennart Rudolf Director | AVI Biopharma, Inc. (SRPT) | 04-Aug-23 | Option Exercise | 15,000 | $29.03 | $435,450.00 | 71% 20.99K to 35.99K | |
| 05-Jun-23 8:00 PM View: | Brown Ryan Edward EVP, General Counsel | AVI Biopharma, Inc. (SRPT) | 01-Jun-23 | Payment of Exercise | 89 | $123.60 | $11,000.40 | (< 1%) 28.18K to 28.1K | |
| 04-Apr-23 8:00 PM View: | Arif Bilal Chief Tech Ops Officer | AVI Biopharma, Inc. (SRPT) | 30-Mar-23 | Payment of Exercise | 307 | $136.66 | $41,954.60 | (1%) 26.67K to 26.37K | |
| 10-Mar-23 8:00 PM View: | Rodino-Klapac Louise Head of R&D, CSO | AVI Biopharma, Inc. (SRPT) | 08-Mar-23 | Payment of Exercise | 912 | $153.19 | $139,709.00 | (1%) 71.08K to 70.17K | |
| 10-Mar-23 8:00 PM View: | Brown Ryan Edward SVP, General Counsel | AVI Biopharma, Inc. (SRPT) | 08-Mar-23 | Payment of Exercise | 635 | $153.19 | $97,275.60 | (2%) 28.82K to 28.18K | |
| 10-Mar-23 8:00 PM View: | Arif Bilal Chief Tech Ops Officer | AVI Biopharma, Inc. (SRPT) | 08-Mar-23 | Payment of Exercise | 314 | $153.19 | $48,101.70 | (1%) 26.99K to 26.67K | |
| 10-Mar-23 8:00 PM View: | Estepan Ian Michael Chief Financial Officer | AVI Biopharma, Inc. (SRPT) | 08-Mar-23 | Payment of Exercise | 744 | $153.19 | $113,973.00 | (2%) 35.42K to 34.68K | |
| 08-Mar-23 8:00 PM View: | Nicaise Claude Director | AVI Biopharma, Inc. (SRPT) | 06-Mar-23 | Grant | 1,523 | -- | -- | 10% 14.8K to 16.33K |
